Orthocell Limited (ASX:OCC) has issued 1,000,000 unquoted options exercisable at $1.2456 and expiring 30 September 2028, according to an Appendix 3G filing lodged on 10 November 2026, with the options issued as consideration under an agreement for the provision of marketing services in the United States.

Key Points

  • 1,000,000 unquoted options were issued on 10 November 2026, with an exercise price of AUD $1.2456 and an expiry date of 30 September 2028.
  • The options were issued as non-cash consideration in accordance with the terms of an agreement for the provision of marketing services in the USA.
  • The securities were issued using the company's 15% placement capacity under ASX Listing Rule 7.1, without security holder approval.
  • Upon exercise, the options convert into OCC ordinary fully paid shares, with 272,393,711 ordinary shares currently on issue.

Option Terms and Issue Details

The options, described as a new class pending an ASX security code, carry an exercise price of AUD $1.2456 and expire on 30 September 2028. The securities are denominated in Australian dollars and are unquoted on ASX. Upon exercise or conversion, the options will result in the issue of OCC ordinary fully paid shares. The filing states that the terms and conditions of the options were lodged with ASX on 10 November 2026, and ASX has confirmed that the terms of the securities are appropriate and equitable under Listing Rule 6.1.

Marketing Services Agreement Consideration

According to the filing, the 1,000,000 options were not issued for cash consideration. Instead, they were issued in accordance with the terms of an agreement for the provision of marketing services in the USA. The filing does not disclose the identity of the counterparty to the agreement, the duration of the services arrangement, or any other financial terms associated with the marketing services agreement. The issue was also notified to ASX via a corresponding Appendix 3B lodged on 10 November 2026.

Orthocell Unquoted Securities on Issue Following Notification

Following the issue, Orthocell's unquoted securities comprise multiple classes of options and rights. These include, among others, 4,000,000 options expiring 29 May 2028 at $0.40, 3,000,000 options expiring 31 October 2027 at $0.67, 3,482,512 retention rights, and 2,046,960 performance rights. The newly issued class of 1,000,000 options expiring 30 September 2028 at $1.2456 is awaiting an ASX security code. The company's total quoted ordinary fully paid shares on issue stand at 272,393,711 as reflected in the filing.